Wang, Y.; Wozniak, A.; Cornillie, J.; Avilés, P.; Debiec-Rychter, M.; Sciot, R.; Schöffski, P.
Plocabulin, a Novel Tubulin Inhibitor, Has Potent Antitumour Activity in Patient-Derived Xenograft Models of Soft Tissue Sarcoma. Int. J. Mol. Sci. 2022, 23, 7454.
https://doi.org/10.3390/ijms23137454
AMA Style
Wang Y, Wozniak A, Cornillie J, Avilés P, Debiec-Rychter M, Sciot R, Schöffski P.
Plocabulin, a Novel Tubulin Inhibitor, Has Potent Antitumour Activity in Patient-Derived Xenograft Models of Soft Tissue Sarcoma. International Journal of Molecular Sciences. 2022; 23(13):7454.
https://doi.org/10.3390/ijms23137454
Chicago/Turabian Style
Wang, Yannick, Agnieszka Wozniak, Jasmien Cornillie, Pablo Avilés, Maria Debiec-Rychter, Raf Sciot, and Patrick Schöffski.
2022. "Plocabulin, a Novel Tubulin Inhibitor, Has Potent Antitumour Activity in Patient-Derived Xenograft Models of Soft Tissue Sarcoma" International Journal of Molecular Sciences 23, no. 13: 7454.
https://doi.org/10.3390/ijms23137454
APA Style
Wang, Y., Wozniak, A., Cornillie, J., Avilés, P., Debiec-Rychter, M., Sciot, R., & Schöffski, P.
(2022). Plocabulin, a Novel Tubulin Inhibitor, Has Potent Antitumour Activity in Patient-Derived Xenograft Models of Soft Tissue Sarcoma. International Journal of Molecular Sciences, 23(13), 7454.
https://doi.org/10.3390/ijms23137454